Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: hospital

In Memoriam: Robert W. Lightfoot Jr., MD

Hammad Ali, MD, William Neal Roberts, MD, & Kristine M. Lohr, MD, MS  |  

On Nov. 4, 2022, the world lost a learned professor, a dedicated doctor, an inquisitive scientist, an adept clinician and, above all, an epitome of Athena’s representation of Mentor in Homer’s Odyssey. Robert W. Lightfoot Jr., MD, had come a long way. Born in 1937, toward the end of the Great Depression, in Nashville, Tenn.,…

In Memoriam: Remembering Richard Brasington Jr., MD, FACP, MACR

Elizabeth Hofheinz, MPH, MEd  |  

On April 30, 2023, the world lost Richard Brasington Jr., MD, FACP, MACR, an illustrious clinical puzzle master who stopped at nothing to do right by his patients—and to ensure the next generation of rheumatologists would be properly trained. Dr. Brasington, a former associate editor of The Rheumatologist and emeritus professor of medicine at Washington…

The 2023 ARP President’s Awards

Patrice Fusillo  |  

SAN DIEGO—During ACR Convergence 2023 in November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the recipients of the ARP President’s Awards. The ARP president can choose to honor ACR/ARP members or teams performing outstanding…

What Every Clinician Should Know about Ramadan & Intermittent Fasting

Mohammad A. Ursani, MD, FACP, RhMSUS, Iman Qaiser, MD, & Mamdouh Mahmoud, PhD  |  

Intermittent fasting—defined as alternating between cycles of eating and going without food over a given period of time—has become popular with individuals seeking to lose weight or balance their lifestyle in recent years. During Ramadan (a period based on the Gregorian calendar that changes from year to year), able-bodied Muslims are obligated to observe a…

Good Care: Benefits of Pain Self-Management Is Getting More Recognition

  |  

Pain management can involve more than active pharmacologic treatment. During a session at ACR Convergence 2023, experts addressed the benefits of patient self-management for pain, how it works with clinical care and the role of technology.

Study Assesses Sarilumab for Polymyalgia Rheumatica

  |  

In an ACR Convergence 2022 session, Robert Spiera, MD, director of the Scleroderma, Vasculitis, and Myositis Center at the Hospital for Special Surgery, New York City, discussed the use of sarilumab as a potential glucocorticoid-sparing therapy in a phase 3 study in patients with treatment-refractory polymyalgia rheumatica (PMR), one of the most common inflammatory diseases…

FDA Approves Sarilumab for Adults with Glucocorticoid-Resistant Polymyalgia Rheumatica

  |  

On Feb. 28, 2023, the U.S. Food & Drug Administration (FDA) approved sarilumab (Kevzara) for the treatment of adults with polymyalgia rheumatica (PMR) for whom glucocorticoids have proved inadequate or who cannot tolerate a glucocorticoid taper.1,2 Sarilumab is an interleukin (IL) 6 receptor antagonist. In May 2017, the FDA initially approved the agent for the…

How to Treat Refractory Polymyalgia Rheumatica

Katie Robinson  |  

Patients with polymyalgia rheumatica (PMR) who had relapsed while tapering glucocorticoid therapy were more likely to achieve sustained remission at one year and have a lower glucocorticoid exposure if they were treated with sarilumab (Kevzara) plus a rapid, 14-week glucocorticoid taper than if they received placebo plus a standard, 52-week glucocorticoid taper. This is according…